If you have a medical emergency, call 911
TRIUMPH-2 data will support a combined obesity-and-diabetes indication
Its triple-action mechanism seems to make it particularly effective for those with significant weight loss goals
The interconnection between the digestive system and taste perception means that gastrointestinal disturbances often manifest as altered taste experiences, even when the taste buds themselves are functioning normally
Patient Support (100/100), Legitimacy ( 97/100 ), and Medication Handling ( 94/100 ) round out a strong clinical foundation
BMI of 30 or higher , or 27 or higher with weight-related conditions such as type 2 diabetes, high blood pressure, or high cholesterol Adults seeking medical weight loss support under professional supervision Patients committed to diet and exercise changes alongside treatment Individuals able to attend follow-up care and ongoing monitoring Semaglutide may not be appropriate during pregnancy or breastfeeding , and treatment suitability should be determined through consultation with a qualified healthcare provider
